endralazine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryFive and 10 mg single oral doses of a new vasodilator antihypertensive, endralazine (E) were given on separate occasions…
SummaryEndralazine (E), a new hydralazine-like antihypertensive was given intravenously (0.05 mg/kg) to 10 normal volunteers (5…
A comparative study of the effects of captopril, an angiotensin converting enzyme inhibitor and endralazine, a new vasodilator…
A comparative, controlled, open hypertension study using the direct vasodilator endralazine and the ACE-inhibitor captopril in…
Endralazine is a peripherally-acting vasodilator with chemical and pharmacological similarities to hydralazine. In both…
This study compared the efficacy of a beta-blocker, pindolol, and a diuretic, clopamide, plus a vasodilator, endralazine, in the…
Endralazine, a new peripheral vasodilator, was studied in 21 patients with hypertension and chronic renal failure. Nineteen…
Endralazine, a new peripheral vasodilator, was given in conjunction with a beta-blocker to 21 patients with hypertension and…
Summary We attempted to characterize six vasodilators with respect to their arterial or venous activity by studying their…
SIR: It has been clearly demonstrated that the high density lipoprotein cholesterol (HDL) concentration is a more accurate…